<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02252250</url>
  </required_header>
  <id_info>
    <org_study_id>20141056</org_study_id>
    <nct_id>NCT02252250</nct_id>
  </id_info>
  <brief_title>Transanal Minimal Invasive Surgery Versus Conventional Laparoscopic Surgery for Rectal Cancer</brief_title>
  <official_title>A Prospective Cohort Study of Transanal Laparoscopic Total Mesentery Excision Versus Conventional Laparoscopic Surgery for Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigates the feasibility, practicability, safety and subjective as well as functional
      outcome of transanal minimal invasive surgery toal mesentery excision for rectal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Natural orifice transluminal endoscopic surgery (NOTES) give the opportunity to reduce
      surgical access trauma leading to a more painless surgery and enhancing a fast postoperative
      recovery. Experience with transanal minimal invasive surgery(TAMIS) for rectal cancer show
      that such NOTES procedures are feasible and safe. And also, lots of experimental studies and
      small case series reporting the feasibility of transanal anterior resection with single
      incision laparoscopic surgery(SILS) port or other devices. However any prospective
      feasibility study demonstrating the safety of the procedure and functional outcomes
      (sphincter function, sexual function, QOF) are missing. This study investigates the
      feasibility, practicability, safety and subjective as well as functional outcome of transanal
      minimal invasive total mesentery excision for rectal cancer.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adequacy of the total mesorectal excision(TME) based on standard guidelines on pathologic evaluation of TME specimens.</measure>
    <time_frame>1-6 years</time_frame>
    <description>Lymph nodes number; rate of positive circumferential resection margin(CRM);</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of 30-day perioperative complications including intraoperative, and postoperative complications</measure>
    <time_frame>0-30 days</time_frame>
    <description>bleeding, injury of adjacent organs, ileus, leakage, infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of long-term complications</measure>
    <time_frame>1-6 years</time_frame>
    <description>incision hernia,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncologic outcomes in subjects receiving transanal hybrid-laparoscopic total mesentery excision.</measure>
    <time_frame>1-6 years</time_frame>
    <description>overall survive rate and disease free survive rate of 3 and 5 years; recurrence rate</description>
  </secondary_outcome>
  <other_outcome>
    <measure>defecating functional outcomes</measure>
    <time_frame>1-6 years</time_frame>
    <description>constipation score and incontinence score</description>
  </other_outcome>
  <other_outcome>
    <measure>sexual functional outcomes</measure>
    <time_frame>1-6 years</time_frame>
    <description>We examine before operation, 3 months after, 6 months after, 12 months after, 24 months after operation, by questionnaires (International Index of Erectile Function (IIEF)</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life outcomes evaluation</measure>
    <time_frame>1-6 years</time_frame>
    <description>We examine before operation, 3 months after, 6 months after, 12 months after, 24 months after operation, by questionnaires (Short Form-36 (SF36) and Gastro-Intestinal Functional Outcome(GIFO)) .</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>conventional laparoscopic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional laparoscopic total mesentery excision surgery for rectal cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transanal hybrid-laparoscopic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transanal hybrid-laparoscopic total mesentery excision surgery for rectal cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional laparoscopic total mesentery excision</intervention_name>
    <description>conventional laparoscopic total mesentery excision</description>
    <arm_group_label>conventional laparoscopic</arm_group_label>
    <other_name>LTME</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transanal hybrid-laparoscopic total mesentery excision</intervention_name>
    <description>transanal laparoscopic total mesentery excision for rectal cancer. Mobilize the rectum from down- to-up. Then, set a single incision laparoscopic surgery (SILS) port at the right-low abdomen to resect the lymph nodes of IMA.</description>
    <arm_group_label>Transanal hybrid-laparoscopic</arm_group_label>
    <other_name>TLTME</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Biopsy-proven adenocarcinoma of the rectum

          -  Eligible to undergo conventional laparoscopic low anterior resection or transanal
             hybrid-laparoscopic low anterior resection with or without a temporary diverting stoma

          -  Node negative (N0), T1 (high risk features), T2 and T3 rectal cancer on pelvic MRI

          -  Closest distance between tumor edge and mesorectal fascia 5mm or more based on pelvic
             MRI

          -  Rectal cancer located 3-10 cm from the anal verge

        Exclusion Criteria:

          -  Metastasis

          -  Obstructing rectal cancer

          -  Synchronous colon cancer

          -  T4 rectal cancer not treated preoperatively with full-course chemoradiation

          -  Pregnant or breast-feeding

          -  Receiving any other study agents

          -  Fecal incontinence

          -  History of prior colorectal cancer

          -  History of inflammatory bowel disease

          -  History of pelvic radiation

          -  BMI &gt; 40

          -  Large uterine fibroids

          -  Uncontrolled intercurrent illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weidong Tong, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Daping Hospital, Third Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Weidong Tong, Prof</last_name>
    <phone>86-023-68757956</phone>
    <email>tongweidong@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Weidong Tong, Prof</last_name>
    <phone>86-13500321218</phone>
    <email>vdtong@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Daping hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weidong Tong, Prof</last_name>
      <phone>86-023-68757956</phone>
      <email>tongweidong@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Weidong Tong, Prof</last_name>
      <phone>86-13500321218</phone>
      <email>vdtong@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2014</study_first_submitted>
  <study_first_submitted_qc>September 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2014</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Third Military Medical University</investigator_affiliation>
    <investigator_full_name>Weidong Tong</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>rectal cancer</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>NOTES</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

